Literature DB >> 2466404

Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast.

R H Wetzels1, R Holland, U J van Haelst, E B Lane, I M Leigh, F C Ramaekers.   

Abstract

Using immunohistochemistry, the distribution patterns of basement membrane components type VII collagen (monoclonal antibody LH7.2), type IV collagen, and laminin were investigated in normal and malignant human breast tissue and compared with that of keratin 14 (monoclonal antibody LL002), which is expressed only by the basal (myoepithelial) cells in the secretory epithelia of the mammary gland. In normal breast tissue as well as in intraductal carcinomas, a more or less continuous basement membrane was observed at the epithelial stromal interface. Unlike laminin and type IV collagen, type VII collagen was not detected in the basement membrane of blood vessels. The keratin 14 antibody stained the basal cell layer of normal ducts and ducts with in situ cancer. In 85% of the invasive carcinomas no basement membrane or basal cells were detected. In 13 cases, however, laminin, type IV collagen, and/or type VII collagen were detected around tumor nests and individual tumor cells. Five of these tumors also showed a positive reaction with the keratin 14 antibody. In five cases keratin 14 expression was found without detectable basement membrane components. It is concluded that 18 of 103 invasive ductal breast carcinomas examined in this study exhibit a basal cell phenotype as determined from the expression of keratin and the deposition of basement membrane components.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2466404      PMCID: PMC1879526     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

Review 1.  Recent studies on the structure and pathology of basement membranes.

Authors:  D R Abrahamson
Journal:  J Pathol       Date:  1986-08       Impact factor: 7.996

2.  Distribution of myoepithelial cells and basement membrane proteins in the resting, pregnant, lactating, and involuting rat mammary gland.

Authors:  M J Warburton; D Mitchell; E J Ormerod; P Rudland
Journal:  J Histochem Cytochem       Date:  1982-07       Impact factor: 2.479

3.  Loss of basement membrane components by invasive tumors but not by their benign counterparts.

Authors:  S H Barsky; G P Siegal; F Jannotta; L A Liotta
Journal:  Lab Invest       Date:  1983-08       Impact factor: 5.662

4.  Antigens of the basement membrane and the peritumoral stroma in human colonic adenocarcinomas: an immunofluorescence study.

Authors:  P Burtin; G Chavanel; J M Foidart; E Martin
Journal:  Int J Cancer       Date:  1982-07-15       Impact factor: 7.396

5.  Isolation of a subunit of laminin and its role in molecular structure and tumor cell attachment.

Authors:  C N Rao; I M Margulies; T S Tralka; V P Terranova; J A Madri; L A Liotta
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

6.  Redistribution of fibronectin and cytoskeletal proteins during the differentiation of rat mammary tumor cells in vitro.

Authors:  M J Warburton; L P Head; P S Rudland
Journal:  Exp Cell Res       Date:  1981-03       Impact factor: 3.905

7.  Basal lamina and tissue recognition in malignant mammary tumors.

Authors:  D R Pitelka; S T Hamamoto; B N Taggart
Journal:  Cancer Res       Date:  1980-05       Impact factor: 12.701

8.  Isolation and partial characterization of a new human collagen with an extended triple-helical structural domain.

Authors:  H Bentz; N P Morris; L W Murray; L Y Sakai; D W Hollister; R E Burgeson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

9.  Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases.

Authors:  B A Gusterson; M J Warburton; D Mitchell; M Ellison; A M Neville; P S Rudland
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

10.  Basement membrane changes in breast cancer detected by immunohistochemical staining for laminin.

Authors:  R Albrechtsen; M Nielsen; U Wewer; E Engvall; E Ruoslahti
Journal:  Cancer Res       Date:  1981-12       Impact factor: 12.701

View more
  37 in total

Review 1.  Control of normal mammary epithelial phenotype by integrins.

Authors:  C H Streuli; G M Edwards
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

2.  Mutated c-Ha-ras oncogene alters cytokeratin expression in the human breast epithelial cell line MCF-10A.

Authors:  T M Paine; G Fontanini; F Basolo; I Geronimo; J W Elliott; J Russo
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

Review 3.  Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine.

Authors:  Ashley G Rivenbark; Siobhan M O'Connor; William B Coleman
Journal:  Am J Pathol       Date:  2013-08-27       Impact factor: 4.307

Review 4.  How malignant is malignant? A brief review of the microscopic assessment of human neoplasms, and the prediction of whether they will metastasize and kill.

Authors:  I Carr; N Pettigrew
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

Review 5.  Evolution and development of Hertwig's epithelial root sheath.

Authors:  Xianghong Luan; Yoshihiro Ito; Thomas G H Diekwisch
Journal:  Dev Dyn       Date:  2006-05       Impact factor: 3.780

6.  Cytokeratin intermediate filament expression in benign and malignant breast disease.

Authors:  M Heatley; P Maxwell; C Whiteside; P Toner
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

7.  Cytokeratin expression in human thymus: immunohistochemical mapping.

Authors:  E Shezen; E Okon; H Ben-Hur; O Abramsky
Journal:  Cell Tissue Res       Date:  1995-01       Impact factor: 5.249

8.  Epidemiology of basal-like breast cancer.

Authors:  Robert C Millikan; Beth Newman; Chiu-Kit Tse; Patricia G Moorman; Kathleen Conway; Lynn G Dressler; Lisa V Smith; Miriam H Labbok; Joseph Geradts; Jeannette T Bensen; Susan Jackson; Sarah Nyante; Chad Livasy; Lisa Carey; H Shelton Earp; Charles M Perou
Journal:  Breast Cancer Res Treat       Date:  2007-06-20       Impact factor: 4.872

9.  Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells.

Authors:  Yi Li; Bryan Welm; Katrina Podsypanina; Shixia Huang; Mario Chamorro; Xiaomei Zhang; Tracey Rowlands; Mikala Egeblad; Pam Cowin; Zena Werb; Lee K Tan; Jeffrey M Rosen; Harold E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

Review 10.  Demystifying basal-like breast carcinomas.

Authors:  L Da Silva; C Clarke; S R Lakhani
Journal:  J Clin Pathol       Date:  2007-05-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.